The Anderson Analysis

Indra’s major US transit contracts are more than just tech upgrades. They represent a calculated market entry backed by local manufacturing and high stakes.

Tredegar posts impressive Q2 profits, but a closer look reveals a tale of two segments and a major corporate overhaul aimed at long-term resilience.

With Oaktree's long chapter closed, asset manager Brookfield is now the ultimate power behind a key TORM shareholder. What does this shift mean for the tanker giant?

Interface posted stellar Q2 results, but a one-time $15.6M tariff refund inflated the numbers. The real story is the operational resilience of its strategy.

While Q2 results show a net loss, Bridger Aerospace secures record contracts and expands its tech, signaling a strategic shift for a new era of wildfire.

A drastic guidance cut and withdrawn cash flow forecast reveal QuidelOrtho's struggle with China's new policies and a post-pandemic diagnostics slump.

Xeriant's NEXBOARD promises a new era of resilient, sustainable construction. But can its impressive performance overcome the company's precarious financial footing?

One specialty clinic cut no-shows by 85% and grew a key program by 600%. We analyze the numbers, the tech, and the strategy behind the hype.

Eaton's $7M Air Force contract aims to use quantum computing for grid security. Is this a true leap forward or a costly experiment in an unproven field?

Bliss Baby brings its 'spa-level' care to Walmart. We analyze the strategy, from its generational appeal to its high-stakes bet on premiumizing the mass market.

Lummus Technology's acquisition of Shell's emissions control unit is more than a simple transaction; it's a calculated move to dominate the industrial decarbonization market.

PracticeQ's new AI Forms promises to digitize patient paperwork in minutes. We analyze if this is a true efficiency leap or just another layer of tech.

Athelas claims its 'agentic' AI suite will revolutionize clinic operations. The Anderson Analysis digs into the tech, the 10x claims, and the human cost.

With $20M in new capital, Ordway is doubling down on AI to automate the quote-to-cash mess. But can its profitable growth model redefine FinTech?

Sprott’s AUM fell 15% on a precious metals slump, yet key metrics soared year-over-year. A critical look at a firm weathering volatility via diversification.

Workiva crushes Q2 estimates, hitting profit targets a year early. A deep dive into how its ‘agentic-first’ AI is redefining the blueprint for success.

Alliance One's new climate-resilient tobacco seeds promise higher yields for Tanzanian farmers, but they also entrench a crop with a heavy public health toll.

ConnX's new statewide deal is more than a procurement win; it's a critical test case for modernizing government and a look into the challenges of execution.

Enpro's Q2 results reveal a powerful strategy: leveraging the AI-driven semiconductor boom to deliver record growth while navigating a mixed industrial landscape.

IIP's Q2 results show a REIT in transition. While actively managing tenant defaults in its core cannabis portfolio, a major $270M bet on life sciences begins to pay off.